292 related articles for article (PubMed ID: 27487775)
21. Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi.
Cataldo F; Chiwaula L; Nkhata M; van Lettow M; Kasende F; Rosenberg NE; Tweya H; Sampathkumar V; Hosseinipour M; Schouten E; Kapito-Tembo A; Eliya M; Chimbwandira F; Phiri S;
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):517-522. PubMed ID: 28045712
[TBL] [Abstract][Full Text] [Related]
22. Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study.
DiCarlo AL; Gachuhi AB; Mthethwa-Hleta S; Shongwe S; Hlophe T; Peters ZJ; Zerbe A; Myer L; Langwenya N; Okello V; Sahabo R; Nuwagaba-Biribonwoha H; Abrams EJ
BMC Health Serv Res; 2019 Apr; 19(1):210. PubMed ID: 30940149
[TBL] [Abstract][Full Text] [Related]
23. Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
Tweya H; Keiser O; Haas AD; Tenthani L; Phiri S; Egger M; Estill J
AIDS; 2016 Mar; 30(6):953-62. PubMed ID: 26691682
[TBL] [Abstract][Full Text] [Related]
24. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
[TBL] [Abstract][Full Text] [Related]
25. Awareness and perceived fairness of Option B+ in Malawi: A population-level perspective.
Yeatman S; Trinitapoli J
J Int AIDS Soc; 2017 Mar; 20(1):21467. PubMed ID: 28362070
[TBL] [Abstract][Full Text] [Related]
26. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
[TBL] [Abstract][Full Text] [Related]
27. Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi.
Kim MH; Ahmed S; Hosseinipour MC; Giordano TP; Chiao EY; Yu X; Nguyen C; Chimbwandira F; Kazembe PN; Abrams EJ
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e77-83. PubMed ID: 25585302
[TBL] [Abstract][Full Text] [Related]
28. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
[TBL] [Abstract][Full Text] [Related]
29. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(8):148-51. PubMed ID: 23446514
[TBL] [Abstract][Full Text] [Related]
30. Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.
Chi BH; Mutale W; Winston J; Phiri W; Price JT; Mwiche A; Ayles H; Stringer JSA
Pediatr Infect Dis J; 2018 Nov; 37(11):1137-1141. PubMed ID: 29601456
[TBL] [Abstract][Full Text] [Related]
31. Trends in ART Initiation among Men and Non-Pregnant/Non-Breastfeeding Women before and after Option B+ in Southern Malawi.
Dovel K; Yeatman S; van Oosterhout JJ; Chan A; Mantengeni A; Landes M; Bedell R; Kawalazira G; Sodhi S
PLoS One; 2016; 11(12):e0165025. PubMed ID: 28002413
[TBL] [Abstract][Full Text] [Related]
32. Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.
Price AJ; Kayange M; Zaba B; Chimbwandira FM; Jahn A; Chirwa Z; Dasgupta AN; Katundu C; Saul JL; Glynn JR; Koole O; Crampin AC
Sex Transm Infect; 2014 Jun; 90(4):309-14. PubMed ID: 24714445
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
Fatti G; Shaikh N; Eley B; Grimwood A
AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
[TBL] [Abstract][Full Text] [Related]
34. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
Tenthani L; Haas AD; Tweya H; Jahn A; van Oosterhout JJ; Chimbwandira F; Chirwa Z; Ng'ambi W; Bakali A; Phiri S; Myer L; Valeri F; Zwahlen M; Wandeler G; Keiser O
AIDS; 2014 Feb; 28(4):589-598. PubMed ID: 24468999
[TBL] [Abstract][Full Text] [Related]
35. PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.
Chagomerana MB; Miller WC; Pence BW; Hosseinipour MC; Hoffman IF; Flick RJ; Tweya H; Mumba S; Chimbwandira F; Powers KA
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):367-374. PubMed ID: 27875363
[TBL] [Abstract][Full Text] [Related]
36. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with retention in Option B+ in Malawi: a case control study.
Hoffman RM; Phiri K; Parent J; Grotts J; Elashoff D; Kawale P; Yeatman S; Currier JS; Schooley A
J Int AIDS Soc; 2017 Apr; 20(1):21464. PubMed ID: 28453243
[TBL] [Abstract][Full Text] [Related]
38. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi.
Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Harrington BJ; DiPrete B; Wallie S; Jumbe A; Limarzi L; Hosseinipour MC
PLoS One; 2018; 13(12):e0209052. PubMed ID: 30543685
[TBL] [Abstract][Full Text] [Related]
40. Measuring retention in care for HIV-positive pregnant women in Prevention of Mother-to-Child Transmission of HIV (PMTCT) option B+ programs: the Mozambique experience.
Ahoua L; Arikawa S; Tiendrebeogo T; Lahuerta M; Aly D; Becquet R; Dabis F
BMC Public Health; 2020 Mar; 20(1):322. PubMed ID: 32164601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
